eFFECTOR Therapeutics Inc (FRA:LWK)
€ 1.07 -0.005 (-0.47%) Market Cap: 5.14 Mil Enterprise Value: 345,000.00 PE Ratio: 0 PB Ratio: 5.52 GF Score: 21/100

eFFECTOR Therapeutics Inc Provides Positive Clinical Data Update for Zotatifin and General Corporate Update Call Transcript

Jan 05, 2023 / 09:30PM GMT
Release Date Price: €17.25 (+65.07%)
Mike Byrnes
eFFECTOR Therapeutics, Inc. - CFO

Good afternoon and thank you for joining us today. Before we start, we encourage you to view the slides for this webcast as well as the press release issued this afternoon, both of which are accessible on our website in the Investors section.

During today's call, we will be making forward-looking statements covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. Actual results could differ materially from those projected in these forward-looking statements due to risks and uncertainties associated with eFFECTOR 's business. These forward-looking statements are qualified by the cautionary statements contained in eFFECTOR 's SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q and eFFECTOR 's press releases including today's release.

This call contains time-sensitive information that is accurate only as of the date of this live broadcast. eFFECTOR undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot